文献速递银屑病与炎症性皮肤病

IL-17C+IL-6KO小鼠中替代性促炎细胞因子诱导维持银屑病样皮肤炎症

Induction of Alternative Proinflammatory Cytokines Accounts for Sustained Psoriasiform Skin Inflammation in IL-17C+IL-6KO Mice.
PubMed 文献 · J Invest Dermatol · 2016-10-27

IL-6抑制治疗银屑病无效,且IL-6阻断后类风湿关节炎患者可出现新发银屑病。研究者将IL-17C+银屑病样小鼠与IL-6缺陷小鼠回交,发现IL-17C+KO小鼠皮肤炎症初期减轻但迅速反弹,伴随Tnf、Il36α/β/γ、Il24、Epgn、S100a8/a9升高至高于IL-17C+小鼠水平。转录组比较显示IL-17C+KO小鼠皮肤与人类银屑病皮肤显著相关,提示角质形成细胞在IL-6缺失时产生更多促炎因子。

要点

  • IL-6缺失导致银屑病样炎症短暂减轻后迅速反弹。
  • 反弹伴随Tnf、Il36α/β/γ、Il24等促炎因子表达升高。
  • IL-17C+KO小鼠皮肤转录组与人类银屑病皮肤显著相关。

核心结论

  • IL-6缺失时角质形成细胞上调多种替代性促炎细胞因子,维持银屑病样皮肤炎症。
  • 该机制可能解释IL-6阻断治疗银屑病无效及诱发新发银屑病。

研究设计与样本

  • 将IL-17C+银屑病样小鼠与IL-6缺陷小鼠回交建立IL-17C+KO小鼠。
  • 比较IL-17C+与IL-17C+KO小鼠皮肤表型及转录组,并与人类银屑病皮肤转录组比较。
  • 对原代角质形成细胞进行转录分析。

主要发现

  • IL-17C+KO小鼠皮肤炎症初期减轻但迅速逆转。
  • IL-17C+KO小鼠皮肤Tnf、Il36α/β/γ、Il24、Epgn、S100a8/a9水平高于IL-17C+小鼠。
  • IL-17C+KO小鼠皮肤转录组与人类银屑病皮肤显著相关,炎症特征加剧。
  • IL-17C+KO原代角质形成细胞促炎分子表达增加。

临床怎么用

  • 提示IL-6阻断治疗银屑病可能无效,并需警惕新发银屑病。
  • 靶向IL-6时需考虑替代性促炎细胞因子通路的代偿。

局限性

  • 为临床前小鼠模型研究,结论需在人体中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IL-6 inhibition has been unsuccessful in treating psoriasis, despite high levels of tissue and serum IL-6 in patients. In addition, de novo psoriasis onset has been reported after IL-6 blockade in patients with rheumatoid arthritis. To explore mechanisms underlying these clinical observations, we backcrossed an established psoriasiform mouse model (IL-17C+ mice) with IL-6-deficient mice (IL-17C+KO) and examined the cutaneous phenotype. IL-17C+KO mice initially exhibited decreased skin inflammation; however, this decrease was transient and reversed rapidly, concomitant with increases in skin Tnf, Il36α/β/γ, Il24, Epgn, and S100a8/a9 to levels higher than those found in IL-17C+ mice. A comparison of IL-17C+ and IL-17C+KO mouse skin transcriptomes with that of human psoriasis skin revealed significant correlation among transcripts of skin of patients with psoriasis and IL-17C+KO mouse skin, and confirmed an exacerbation of the inflammatory signature in IL-17C+KO mice that aligns closely with human psoriasis. Transcriptional analyses of IL-17C+ and IL-17C+KO primary keratinocytes confirmed increased expression of proinflammatory molecules, suggesting that in the absence of IL-6, keratinocytes increase production of numerous additional proinflammatory cytokines. These preclinical findings may provide insight into why patients with arthritis being treated with IL-6 inhibitors develop new onset psoriasis and why IL-6 blockade for the treatment of psoriasis has not been clinically effective.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Fritz Y, Klenotic PA, Swindell WR, et al. Induction of Alternative Proinflammatory Cytokines Accounts for Sustained Psoriasiform Skin Inflammation in IL-17C+IL-6KO Mice. J Invest Dermatol. 2016. PMID: 27984037. doi:10.1016/j.jid.2016.10.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。